Sun Q, Ye Y, Gui AL, Sun XT, Xie SS, Zhan YH, Chen RB, Yan YC, Gu J, Qiu S, Liu W, Zuo J, Zhang QL, Yang L*. MORTALIN-Ca2+ axis drives innate rituximab resistance in diffuse large B-cell lymphoma. Cancer Lett. 2022
Qiu S, Liu Y, Gui A, Xia Z, Liu W, Gu JJ, Zuo J, Yang L*, Zhang Q.*. Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma. J Cancer. 2022 Jan 4;13(3):998-1004.
Li S, Lv M, Qiu S, Meng J, Liu W, Zuo J, Yang L*. NF-κB p65 promotes ovarian cancer cell proliferation and migration via regulating mortalin. J Cell Mol Med. 2019 Jun;23(6):4338-4348.
Yang L, Sun X, Ye Y, Lu Y, Zuo J, Liu W, Elcock A, Zhu S. p38α Mitogen-Activated Protein Kinase Is a Druggable Target in Pancreatic Adenocarcinoma. Front Oncol. 2019 Nov 26;9:1294.
Yang L, Zhang S, Ling X, Shao P, Jia N, Bai M. Multilayer photodynamic therapy for highly effective and safe cancer treatment. Acta Biomater. 2017 May;54:271-280.
Liu Y, Hu Y, E Q, Zuo J, Yang L*, Liu W*. Salvianolic acid B inhibits mitochondrial dysfunction by up-regulating mortalin. Sci Rep. 2017 Mar 2;7:43097.
Hu Y, Yang L, Yang Y, Han Y, Wang Y, Liu W, Zuo J. Oncogenic role of mortalin contributes to ovarian tumorigenesis by activating the MAPK-ERK pathway. J Cell Mol Med. 2016 Nov;20(11):2111-2121.
Zhang S, Yang L, Ling X, Shao P, Wang X, Edwards WB, Bai M. Tumor mitochondria-targeted photodynamic therapy with a translocator protein (TSPO)-specific photosensitizer. Acta Biomater. 2015 Dec;28:160-170..
Yang L, Li H, Jiang Y, Zuo J, Liu W. Inhibition of mortalin expression reverses cisplatin resistance and attenuates growth of ovarian cancer cells. Cancer Lett. 2013 Aug 9;336(1):213-21.
Yang L, Guo W, Zhang Q, Li H, Liu X, Yang Y, Zuo J, Liu W. Crosstalk between Raf/MEK/ERK and PI3K/AKT in suppression of Bax conformational change by Grp75 under glucose deprivation conditions. J Mol Biol. 2011 Dec 16;414(5):654-66.
